Vol., No. / October 2009
Maintaining wellness in patients with bipolar disorder: moving beyond efficacy to effectivenessContinue to article
Download the CME test
Release date: October 1, 2009
This activity was submitted by SciMed and supported by an educational grant from AstraZeneca. It was peer reviewed by Current Psychiatry and Annals of Clinical Psychiatry.
This activity is designed to meet the needs of psychiatrists and other mental health care professionals interested in the management of patients with bipolar disorder.
Bipolar disorder (BD) is one of the most difficult psychiatric conditions to accurately recognize and diagnose because many patients report depressive, but not manic, symptoms. Additionally, BD is often comorbid with drug and alcohol abuse as well as other psychiatric illnesses, which results in symptoms that are complex and challenging to evaluate and treat. Patients with BD also experience more physical illnesses compared with the general population, and comorbid medical disorders are associated with poor functional outcomes.
Maintaining wellness in patients with BD requires consideration of the potential negative effects BD can have on functioning, quality of life, and interpersonal relationships. Since BD is a chronic disorder, long-term treatment is needed and should include both psychopharmacologic and psychosocial therapies. Evidence exists to support the use of various pharmacotherapies for the effective management of patients with depressive and/or manic symptoms of BD. Treatment optimization depends on the appropriate choice of therapies for individual patients, particularly in cases with coexisting psychiatric and medical conditions.
This activity will provide an evidence-based approach to the treatment of patients with BD using pharmacologic and psychosocial therapies. The efficacy, safety, and tolerability of various treatment interventions will be discussed based on data from the most recent clinical trials. Long-term treatment strategies will be outlined, focusing on enhancement of patient satisfaction, the minimization of adverse events, and improvement of overall patient outcomes.
After completing this activity, participants should be better able to:
• Develop an evidence-based approach to the treatment of patients with BD based on available treatment options
This supplement is based on the live program entitled “Maintaining Wellness in Patients With Bipolar Disorder: Moving Beyond Efficacy to Effectiveness”, held as a lunch symposium on April 3, 2009, at the Westin River North, Chicago, Illinois, in conjunction with the 2009 Current Psychiatry/American Academy of Clinical Psychiatrists meeting, and represents the same content material.
S. Nassir Ghaemi, MD, MPH,
Claudia F. Baldassano, MD,
Robert M. A. Hirschfeld, MD,
SciMed is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SciMed designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure and Resolution of Conflicts of Interest
SciMed assesses conflicts of interest with its faculty and all individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are resolved by SciMed to ensure fair balance and scientific objectivity. When asked to report any potential conflict(s) of interest, faculty reported the following:
Claudia F. Baldassano, MD
Speakers Bureau: AstraZeneca, GlaxoSmithKline, Pfizer Inc
S. Nassir Ghaemi, MD, MPH
Grants/Research Support: Pfizer Inc,
Robert M. A. Hirschfeld, MD
Consultant/Advisory Board: Dainippon Sumitomo Pharma Co., Ltd., Forest Laboratories, Inc., Pfizer Inc, Takeda Pharmaceuticals Inc.,
All SciMed personnel involved in the development of content for this activity have no relevant conflicts to report. The materials for this activity were peer reviewed by Jeffrey Susman, MD, University of Cincinnati, and Donald W. Black, MD, University of Iowa.
There are no fees for participating in and receiving CME credit for this activity. In order to obtain CME credit for participating in this activity between the period October 1, 2009, through October 1, 2010, participants must:
• Read the learning objectives and disclosure statements
A statement of credit will be issued only upon receipt of a completed activity evaluation and a completed posttest with a score of 80% or better. Participants will be mailed a certificate or statement of credit within 4 to 6 weeks.
The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of SciMed or the commercial supporter. Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.
Current Psychiatry ©2009 Quadrant HealthCom Inc.